Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction?

Aliment Pharmacol Ther. 2019 Jan;49(2):229-230. doi: 10.1111/apt.15056.

Authors

Chen-Hua Liu^{1

2}, Jia-Horng Kao^{1

2

3}

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
² Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
³ Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

PMID: 30589963
DOI: 10.1111/apt.15056

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents*
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic*
Humans

Substances

Antiviral Agents
Hepatitis B Surface Antigens